cheisi:	iranchiese@darmanyab.com

People and ideas for innovation in healthcare

The Company, founded in Parma in 1935, is today an international reality in the pharmaceutical market. With global operations consisting of 22 direct affiliates, last but not least Chiesi China, 3 manufacturing sites, and 3 research centres, the Group has over 3,000 employees. The three research and development sites (Italy, France and United States) employ more than 300 people, while the three manufacturing facilities employ about 600 people.

Chiesi’s technologies and products are available in over 50 countries through a strategic alliances network of international pharmaceutical groups developed both on a global and local scale. Group turnover reached 565 million Euros in 2005. Historically, the continuous development of the Company has been based on strategic planning for innovation, internationalisation, socially compatible economical values, and use of effective organizational structures.

Message from the Chairmen

In 2007, the pharmaceutical scenario once again evolved in line with previous years: difficulties in the development of innovative drugs, especially for chronic illnesses; a dramatic increase in the sales of generics,as a result of patent expiries for a number of important products; a decrease in the number of new chemical and biological formulations reaching the market; pressure from health authorities to reduce the cost of pharmaceutical treatments.

Despite this situation, our Group has continued to succeed, achieving higher growth rate than that of the markets in which it operates, thanks to the success of its own products for respiratory and cardiovascular diseases and the treatment of rare diseases.

<Back  (1-2-3-4)  Next>

►Mission & Vision  Darmanyab Darou's first objective is making health accessible to  ...

►Business Development Darmanyab Darou is a fast growing company with an active ...

the best resolution for view: 1280 x 1024